Clinical Trials
10
Active:0
Completed:7
Trial Phases
4 Phases
Phase 1:3
Phase 2:3
Phase 3:1
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials
Not Applicable
3 (30.0%)Phase 1
3 (30.0%)Phase 2
3 (30.0%)Phase 3
1 (10.0%)A Study to Assess the Safety and Efficacy of Nitric Oxide Injection Into Unresectable Solid Primary or Metastatic Tumors
Phase 1
Recruiting
- Conditions
- Cancer
- Interventions
- Drug: Nitric Oxide 50,000 ppmDrug: Nitric Oxide 100,000 ppmDrug: Nitric Oxide selected doseDrug: Nitric Oxide 25,000 ppm
- First Posted Date
- 2022-04-28
- Last Posted Date
- 2024-08-16
- Lead Sponsor
- Beyond Air Inc.
- Target Recruit Count
- 38
- Registration Number
- NCT05351502
- Locations
- 🇮🇱
Soroka Medical Center, Be'er Sheva, Israel
🇮🇱Hadassah Ein-Karem, Jerusalem, Israel
🇮🇱Sheba Medical Center, Ramat Ef'al, Israel
A Pilot Study to Assess the Effect of Intermittent iNO on the Treatment of NTM Lung Infection in CF and Non-CF Patients
Not Applicable
Completed
- Conditions
- Cystic FibrosisMycobacterial PneumoniaMycobacterium Avium ComplexMycobacterium Abscessus InfectionNon-Tuberculous Mycobacterial Pneumonia
- First Posted Date
- 2020-12-28
- Last Posted Date
- 2022-12-16
- Lead Sponsor
- Beyond Air Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT04685720
- Locations
- 🇦🇺
Gallipoli Medical Research Foundation, Greenslopes, Queensland, Australia
Inhaled NO for the Treatment of Viral Pneumonia in Adults
Not Applicable
Completed
- Conditions
- Covid19Respiratory DiseasePneumonia, ViralViral PneumoniaNitric OxideInhaled Nitric OxideSARS-CoV Infection
- First Posted Date
- 2020-10-28
- Last Posted Date
- 2022-12-16
- Lead Sponsor
- Beyond Air Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT04606407
- Locations
- 🇮🇱
Shaare Zedek Medical Center, Jerusalem, Israel
🇮🇱Hasharon Medical Center, Petah Tikva, Israel
🇮🇱Rabin Medical Center, Petah Tikva, Israel
Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (CANADA Trial)
Phase 2
Withdrawn
- Conditions
- SARS-CoV 2Corona Virus InfectionCOVID-19Pneumonia, ViralRespiratory Disease
- First Posted Date
- 2020-07-02
- Last Posted Date
- 2021-01-22
- Lead Sponsor
- Beyond Air Inc.
- Registration Number
- NCT04456088
Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial)
Not Applicable
Terminated
- Conditions
- COVID-19SARS-CoV 2Respiratory DiseaseInhaled Nitric OxideNitric OxidePneumonia, ViralCorona Virus Infection
- First Posted Date
- 2020-05-21
- Last Posted Date
- 2022-12-16
- Lead Sponsor
- Beyond Air Inc.
- Target Recruit Count
- 4
- Registration Number
- NCT04397692
- Locations
- 🇺🇸
Baptist Health Center for Clinical Research, Little Rock, Arkansas, United States
- Prev
- 1
- 2
- Next
News
No news found